Papel de los anti-pd1 en el abordaje de un paciente diagnosticado con melanoma

13 / 40

PFSa in Patients Who Completed Protocol-Specified Time on Pembrolizumab (n = 103)
Presented By Georgina Long at 2018 ASCO Annual Meeting